COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,091 Articles (21,559 medRxiv, 7,532 bioRxiv)

Most recent first Previous |  Page 450: Articles 4491-4500  | Next

Intrahost SARS-CoV-2 k-mer identification method (iSKIM) for rapid detection of mutations of concern reveals emergence of global mutation patterns
Thommana, A. A., Shakya, M., Gandhi, J. S., Fung, C. K., Chain, P., Maljkovic Berry, I., Conte, M. A.
10.1101/2022.08.16.504117 — Posted: 2022-08-16
Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance
Smith, D. R. M., Shirreff, G., Temime, L., Opatowski, L.
10.1101/2022.08.15.503946 — Posted: 2022-08-16
Synchronicity of viral shedding in molossid bat maternity colonies
Hoarau, A. O. G., Köster, M., Dietrich, M., Le Minter, G., Joffrin, L., Ramanantsalama, R. V., Mavingui, P., Lebarbenchon, C.
10.1101/2022.08.16.504085 — Posted: 2022-08-16
QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England
Hippisley-Cox, J., Khunti, K., Sheikh, A., Nguyen-Van-Tam, J., Coupland, C.
10.1101/2022.08.13.22278733 — Posted: 2022-08-16
The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients
Tami, A., van der Gun, B. T., Wold, K. I., Vincenti-Gonzalez, M. F., Veloo, L. A., Knoester, M., Harmsma, V. P., de Boer, G. C., Huckriede, A. L., Pantano, D., Gard, L., Rodenhuis-Zybert, I. A., Upasani, V., Smit, J., Dijkstra, A. E., de Haan, J. J., van Elst, J. M., van den Boogaard, J., OBoyle, S., Nacul, L., Niesters, B. H., Friedriach, A. W.
10.1101/2022.08.14.22278762 — Posted: 2022-08-16
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
Bates, T. A., Lu, P., Kang, Y. j., Schoen, D., Thornton, M., McBride, S. K., Park, C., Kim, D., Messer, W. B., Curlin, M. E., Tafesse, F. G., Lu, L. L.
10.1101/2022.08.12.22278726 — Posted: 2022-08-16
Demographic and Viral-Genetic Analyses of COVID-19 Severity in Bahrain Identify Local Risk Factors and a Protective Effect of Polymerase Mutations
Koch, E. M., Du, J., Dressner, M., Alwasti, H. E., Al Taif, Z., Shehab, F., Mohamed, A. M., Ghanem, A., Haghighi, A., Sunyaev, S., Farhat, M.
10.1101/2022.08.13.22278740 — Posted: 2022-08-16
Performance of the Cue COVID-19 Molecular Test for Point of Care: Insights from a multi-site clinic service model
Rebbapragada, A., Cariazo, L., Elchuk, D., Abdelrahman, H., Pham, D., Joseph, N., Gouzenkova, E., Gill, H., Blecher, P.
10.1101/2022.08.12.22278567 — Posted: 2022-08-16
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Hao, L., Hsiang, T.-Y., Dalmat, R. R., Ireton, R., Morton, J., Stokes, C., Netland, J., Hale, M., Thouvenel, C., Wald, A., Franko, N. M., Huden, K., Chu, H., Greninger, A., Tilles, S., Barrett, L. K., Van Voorhis, W. C., Munt, J., Scobey, T., Baric, R. S., Rawlings, D., Pepper, M., Drain, P. K., Gale, M.
10.1101/2022.08.12.22278720 — Posted: 2022-08-16
Real-world evidence with a retrospective cohort of 15,968 Andalusian COVID-19 hospitalized patients suggests 21 new effective treatments and one drug that increases death risk.
Loucera, C., Carmona, R., Esteban-Medina, M., Bostelmann, G., Munoyerro-Muniz, D., Villegas, R., Pena-Chilet, M., Dopazo, J.
10.1101/2022.08.14.22278751 — Posted: 2022-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).